Mirum Pharmaceuticals, Inc. Common Stock (NASDAQ: MIRM) last traded at $96.31, down 0.78% on the session. The quote above updates while this page is open; the figures below are drawn from Mirum Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Mirum Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker MIRM. Its market capitalisation is $6.25 billion.
Valuation measures for Mirum Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $6.25B |
|---|---|
| Enterprise value | $6.98B |
| Price / sales | 10.12 |
| Beta | 0.98 |
Trailing-twelve-month figures tagged in Mirum Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $618.07M |
|---|---|
| Net income (TTM) | -$860.21M |
| EPS (TTM) | -$14.54 |
| Operating margin | -134.93% |
| Cash | $330.73M |
Range and volume for MIRM over the past 52 weeks.
| 52-week high | $130.00 |
|---|---|
| 52-week low | $63.23 |
| Volume | 685.5K |
| Average volume | 812.9K |
| Previous close | $97.07 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.